Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. (WIRMS-1)

Clinical Trial ID NCT00630383

Rank	Title	Journal	Year	PubWeight™‹?›
1	The effect of infections on susceptibility to autoimmune and allergic diseases.	N Engl J Med	2002	9.26
2	Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.	J Exp Med	2004	8.98
3	A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage.	Nat Med	2007	8.97
4	Multiple sclerosis.	Lancet	2002	7.11
5	Association between parasite infection and immune responses in multiple sclerosis.	Ann Neurol	2007	2.91
6	Multiple sclerosis and the hygiene hypothesis.	Neurology	2006	1.49
7	A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic.	Mult Scler	2004	1.39
8	Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization.	Int Immunol	2003	1.34
9	Dose-ranging study for trials of therapeutic infection with Necator americanus in humans.	Am J Trop Med Hyg	2006	1.11
10	Hookworm infection.	Sci Am	1995	0.98
11	The immunoepidemiology of human hookworm infection.	Parasite Immunol	2005	0.97
12	Parasite role reversal: worms on trial.	Trends Parasitol	2005	0.90
13	Can helminth antigens be exploited therapeutically to downregulate pathological Th1 responses?	Curr Opin Investig Drugs	2004	0.78
14	Worm therapy: How would you like your medicine?	Int J Parasitol Drugs Drug Resist	2012	0.77